Summary of Campylobacter infection surveillance in France in 2022.

Key Points

In 2022, surveillance of Campylobacter infections in France confirmed the epidemiological and biological trends already observed in recent years:

  • a predominance of the C. jejuni species;

  • a higher number of cases and incidence among children;

  • a predominance of infections among men;

  • a seasonal peak during the summer months, except for C. fetus;

  • high resistance to fluoroquinolones and tetracyclines, which has remained stable in recent years;

  • no significant increase in resistance rates for the six antibiotics routinely tested.

In relation to

Our latest news

news

Shamonda Virus: First Human Case Detected in France—What Do We Know?

news

Call for Nominations for the Renewal of the Scientific Advisory Board of the...

news

Growing Up with Screens. A special report in *La Santé en action* No. 474,...